Boston Trust Walden Corp Makes New Investment in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Boston Trust Walden Corp purchased a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 579,538 shares of the company's stock, valued at approximately $41,785,000. Boston Trust Walden Corp owned about 1.17% of Prestige Consumer Healthcare as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Covestor Ltd raised its stake in Prestige Consumer Healthcare by 21.6% during the first quarter. Covestor Ltd now owns 834 shares of the company's stock worth $61,000 after buying an additional 148 shares during the last quarter. Evergreen Capital Management LLC raised its position in shares of Prestige Consumer Healthcare by 5.4% in the 2nd quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company's stock worth $216,000 after acquiring an additional 160 shares in the last quarter. Miller Howard Investments Inc. NY lifted its stake in shares of Prestige Consumer Healthcare by 2.2% in the 2nd quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company's stock valued at $534,000 after purchasing an additional 165 shares during the period. OLD National Bancorp IN boosted its position in shares of Prestige Consumer Healthcare by 4.4% during the 3rd quarter. OLD National Bancorp IN now owns 3,974 shares of the company's stock valued at $287,000 after purchasing an additional 168 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in shares of Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company's stock valued at $33,000 after purchasing an additional 208 shares in the last quarter. Institutional investors own 99.95% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on PBH. DA Davidson boosted their price target on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a "buy" rating in a research note on Wednesday, August 28th. Jefferies Financial Group reiterated a "hold" rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, Prestige Consumer Healthcare currently has an average rating of "Moderate Buy" and an average target price of $94.20.

Prestige Consumer Healthcare Stock Up 0.3 %

Shares of PBH traded up $0.21 during trading hours on Friday, reaching $73.04. The stock had a trading volume of 333,615 shares, compared to its average volume of 246,665. The firm has a 50-day simple moving average of $71.82 and a 200 day simple moving average of $69.39. Prestige Consumer Healthcare Inc. has a 12 month low of $56.61 and a 12 month high of $75.80. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65. The company has a market capitalization of $3.62 billion, a price-to-earnings ratio of 17.86, a P/E/G ratio of 2.03 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, beating analysts' consensus estimates of $0.86 by $0.04. The firm had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The business's quarterly revenue was down 4.4% compared to the same quarter last year. During the same period last year, the firm earned $1.06 earnings per share. Equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.